drugset / Trial / NCT04479891

Effect of Itraconazole on the Pharmacokinetics of Pyrotinib in Healthy Subjects

NCT04479891

Phase 1 Completed 18 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelBasic science

Summary

The study will assess the effect of multiple oral doses of itraconazole on the single dose pharmacokinetic parameters of pyrotinib in healthy Chinese subjects. The safety of pyrotinib alone and when co-administered with itraconazole will also be assessed.

Timeline

Start
2019-09-18
Primary completion
2019-10-11
Completion
2019-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule 200 mg Oral
Subject Pyrotinib Small molecule Oral

Indications

No indication recorded.